Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1864
Full metadata record
DC FieldValueLanguage
dc.contributorHurley, James C.en_US
dc.date.accessioned2022-01-27T04:44:55Z-
dc.date.available2022-01-27T04:44:55Z-
dc.date.issued2021-
dc.identifier.govdoc01848en_US
dc.identifier.urihttp://hdl.handle.net/11054/1864-
dc.descriptionComment on Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure. Johnson SW, Brown SV, Priest DH. Clin Infect Dis. 2020 Aug 22;71(5):1133-1139. doi: 10.1093/cid/ciz966. PMID: 31560051 Clinical Trial.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-12T00:22:05Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-27T04:44:55Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2022-01-27T04:44:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2021en
dc.titleOral Vancomycin Prophylaxis for Clostridioides difficile Infection: Cause or Effect?en_US
dc.typeJournal Articleen_US
dc.type.specifiedLetteren_US
dc.bibliographicCitation.titleClinical Infectious Diseasesen_US
dc.bibliographicCitation.volume73en_US
dc.bibliographicCitation.issue9en_US
dc.bibliographicCitation.stpagee2850en_US
dc.bibliographicCitation.endpagee2851en_US
dc.subject.healththesaurusORAL VANCOMYCINen_US
dc.subject.healththesaurusCLOSTRIDIOIDES DIFFICILEen_US
dc.identifier.doihttps://doi.org/10.1093/cid/ciaa1424en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.